Trials / Conditions / Cerebral Adrenoleukodystrophy
Cerebral Adrenoleukodystrophy
5 registered clinical trials studyying Cerebral Adrenoleukodystrophy — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Suspended | MT2022-01: MSCs for ALD NCT06030648 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Unknown | A Clinical Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the E NCT04528706 | Minoryx Therapeutics, S.L. | Phase 2 |
| Recruiting | Adrenoleukodystrophy National Registry Study NCT03789721 | Masonic Cancer Center, University of Minnesota | — |
| Terminated | Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Condi NCT03367546 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Withdrawn | MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD) NCT02410239 | Masonic Cancer Center, University of Minnesota | Phase 1 |